15 Biotechs Making Announcements At The 2015 Piper Jaffray Healthcare Conference
- Piper Jaffray is hosting its 27th Annual Health Care Conference December 1-2 in New York.
- Public biotechnology, specialty pharmaceuticals, drug discovery, medical technology, and other health care services companies will take part in the event.
- The conference addresses important questions in the health care industry space.
Piper Jaffray's 27th annual Health Care Conference kicked off on Tuesday in New York City with many notable health care service companies taking part in the event and making announcements.
Here is a roundup of 15 companies that have confirmed their attendance in the event:
Abeona Therapeutics Inc (NASDAQ: ABEO) develops and delivers gene therapy and plasma-based products for rare diseases.
Applied Genetic Technologies Corp (NASDAQ: AGTC) is a clinical stage biotechnology company that develops gene therapy products for the treatment of inherited and acquired diseases.
Aratana Therapeutics Inc (NASDAQ: PETX) is a therapeutics company focused on licensing, developing and commercializing of biopharmaceutical products for animals.
C R Bard Inc (NYSE: BCR) designs, manufacturers, packages, distributes, and sales medical, surgical, diagnostic and patient care devices.
Cellectis SA (ADR) (NASDAQ: CLLS) is a France-based company that is active in the field of genome engineering and genomic surgery.
Cepheid (NASDAQ: CPHD) develops, manufactures, and markets systems to enable molecular testing for organisms and genetic-based diseases.
Collegium Pharmaceutical Inc (NASDAQ: COLL) is a specialty pharmaceutical company that plans on commercializing abuse-deterrent products.
ContraFect Corp (NASDAQ: CFRX) is a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases.
CymaBay Therapeutics Inc (NASDAQ: CBAY) is a small-cap biopharmaceutical company that is focused on developing therapies to treat metabolic diseases.
Envision Healthcare Holdings Inc (NYSE: EVHC) provides physician-led, outsourced medical services.
Geron Corporation (NASDAQ: GERN) is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor.
Gilead Sciences, Inc. (NASDAQ: GILD) is an industry leader with a $150 billion-plus market cap to discovers, develops, and commercializes innovative medicines.
NewLink Genetics Corp (NASDAQ: NLNK) is a biopharmaceutical company focused on discovering, developing and commercializing immunotherapeutic products for cancer treatment.
Pfizer Inc. (NYSE: PFE), another industry giant with a $200 billion-plus market cap, is engaged in discovering, developing and manufacturing a wide range of healthcare products.
Summit Therapeutics PLC (ADR) (NASDAQ: SMMT) is a UK-based biopharmaceutical company that is focused on the discovery, development, and commercialization of medicines for indicators in which there exists no adequate therapy.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.